GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI ...

Interim results from the CARE PMR study support the use of ultra-low-field MRI as a triage tool for monitoring patients on amyloid-targeting therapies. Researchers from the Benzinger Lab at Washington ...

The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury (ABI) ...

Hyperfine, Inc. HYPR, a pioneer in health technology, recently announced promising interim data on the Swoop Portable magnetic resonance (MR) Imaging for acute stroke diagnosis. These findings, ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...

GUILFORD, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc., creator of the Swoop® Point-of-Care MRI System™ for imaging of the brain, today announced the acceptance of twelve abstracts related ...

GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI ...

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care Hyperfine, Inc. (Nasdaq: HYPR) ...

New dementia study actively enrolling and new data to be presented at the 2025 Alzheimer's Association International Conference. GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (HYPR) (Nasdaq: HYPR ...